The diagnostic utility of S-100B protein and TPA in patients with ischemic stroke

Neuroendocrinology Letters

Volumn 28, Issue 5, 2007, Pages 693-698

  Kokocińska, Danuta ^a,b   Wieczorek, Piotr ^a   Partyka, Robert ^a   Jarzab, Jerzy ^b   Jałowiecki, Przemysław ^a   Sikora, Jerzy ^b  

^a Department and Clinic of Internal Medicine Diabetology and Nephrology   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Brain infarction; S 100 protein; Stroke

Indexed keywords

PROTEIN S100B; TISSUE POLYPEPTIDE ANTIGEN;

ACUTE DISEASE; ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BARTHEL INDEX; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HUMAN; MALE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RATING SCALE; SCANDINAVIAN STROKE SCALE;

EID: 38049018465     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Chant H, Naser S, Riding G, Fearn S, Blann A, McCollum CM. Is S-100 release related to ischaemia during Carotid Endarterectomy? 8-th European Stroke Conference, Venice, 1999, Cerebrovasc Dis. 1999; 9(suppl 1):44.
2. Di Legge 5, Martinelli O, Di Stani F, Stumpo R, Di Piero V, Perna R, Reale MG, Benedetti Valentini F, Lenzi GL. S-100 protein release during carotid enclarterectomy. 9-th European Stroke Conference, Vienna 2000, Cerebrovasc Dis. 2000; 10(suppl 2): 44.
3. Ingebrigsten T, Romner B. Serial S-100 protein serum measurements related to early magnetic resonance imaging after minor head injury. J Neurosurg. 1996; 85: 945-958.
4. Ingebrigsten T, Waterloo K, Jacobsen E, Langbakk B, Romner B. Traumatic brain damage in minor head injury: Relation of serum S-100 protein measrements to magnetic resonans Imaging and neurobehavioral outcome. Neurosurgery. 1999; 45: 468-476.
5. Wong C, Bonser RS. Serum S-100 protein in stroke and cardiac surgery. Stroke. 1998; 29: 2446. Letter.
6. Wos S, Opala G, Jasinski M, Janas P, Bachowski R, Kus H, Domaradzki W, Gemel M, Deja M, Dyaczynska-Herman A. Wczesne osrodkowe powiklania neurologiczne po operacjach serca w krazeniu pozaustrojowym. Kard Pol. 1997; 47: 115-120.
7. Birkmayer JGD. Markers of central nervous system tumors. Immunol Ser. 1990; 53: 317-322.
8. Gallo V, Cerrutti E, Riberi A, Re M, Petrino R, Pecchio F. Alpha-feto protein and tissue plypepticle antigen in non-neoplastic hepatic disorders. J Nucl Med Allied Sci. 1898; 33: 89-93.
9. Kashibawara K, Nakamura H, Kiguchi T, Matsuoka T. Correlation beetween serum cytokeratin 19 fragment and tissue polypeptide antigen levels in patients with non-malignant diseases. Clin-Chim-Acta. 1998; May 8; 273(1):35-42.
10. Kokocinska D, Olejek A, Grabska T, Gruenpeter P, Pawelek P. Nienowotworowe podwyzszenie surowiczych stezen markerow nowotworowych TPS i TPA. Diagnostyka Laboratoryjna.
11. Büttner T, Weyers S, Postert T, Sprengelmeyer R, Kuhn W. S-100 protein: Serum marker of focal brain damage after ischemic territorial MCA infarction. Stroke. 1997; 28(10): 1961-1965.
12. Missler U, Wiessman M, Friedrich Ch, Kaps M. S-100 protein and Neuron-Specific Enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke. 1997; 28(10):1956-1960.
13. Nygaard O, Langbakk B, Romner B. Age- and sex-related changes of S-100 protein concentrations in cerebrospinal fluid and serum in patients with no previous history of neurological disorder. Clin Chem. 1997; 43: 541-543.
14. Wiessman M, Missler U, Gottman D, Gehring S. Plasma S-100b concentration in healthy adults in age and sex independent. Clin Chem. 1998; 44:1056-1058.
15. Butterworth RJ, Wassif WS, Sherwood RA, Gerges A, Poyser KH, Garthwaite J, Peters TJ, Bath PM. Serum Neuron-Specific Enolase, Carnosinase, and their ratio in acute stroke. Stroke. 1996; 27(11): 2064-2068.
16. Butterworth RJ, Sherwood RA, Bath PM. Serum S-100 protein in acute stroke. Stroke. 1998; 29: 730. Letter.
17. Martens P, Raabe A, Johnsson P. Serum S-100 and Neuron-Specific Enolase for Prediction of Regaining Consciousness After Global cerebral Ischemia. Stroke. 1998; 29: 2363-2366.
18. Ozmen J, Lord RSA, Bobryshev YV, Ashwell, Munro VF. S-100 protein is expressed in induced atherosclerotic lesions of hypercholesterolaemic rats. Biomed Research. 1998; 19(4): 279-287.
19. Wunderlich MT, Ebert AD, KratzT, Goertler M, Jost S, Herrman M. Early neurobehavior outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke. 1999; 30(6): 1190-1195.
20. Abraha HD, Butterworth RJ, Bath PM, Wassif WS, Garthwaite J, Sherwood RA. Serum S-100 protein, relationship to clinical outcome in acute stroke. Ann. Clin. Biochem. 1997, 34: 546-550.
21. Collazos J, Genolla J, Ruibal A. A clinical and biochemical study on tissue polipepticle antigen in nonmalignant hepatic disorders. Scand J Clin Lab Invest. 1993; 53: 633-637.
22. Gion M, Boracchi P, Dittadi R, Biganzoli E, Peloso L, Gatti C, Paccagnella A, Rosabian A, Vinante O, Meo S. Quantitative measurment of soluble cytokeratin fragments in tissue Cytosol of 599 node negative breast cancer patients: a prognostic marker possibly associated with apoptosis. Breast Cancer Res Treat. 2000; 59 (3): 211-221.
23. Foerch C, Otto B, Singer O, Neuman n-Haefelin T, Yan B, Berkefeld J, Steinmetz H, Sitzer M. Serum S10013 Predicts a Malignant Course of Infarction in Patients With Acute Middle Cerebral Artery Occlusion. Stroke. Sep 2004; 35: 2160-2164.
24. Lynch J, Blessing R, White W, Grocott H, Newman M, Laskowitz D. Novel Diagnostic Test for Acute Stroke. Stroke. Jan 2004; 35: 57-63.